<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <title>NutraIngredients Podcast</title>
    <link>http://www.nutraingredients.com</link>
    <description>Breaking News on Supplements &amp; Nutrition - Europe</description>
    <language>en-gb</language>
    <copyright>℗ &amp; © 2013 William Reed Business Media</copyright>
    <managingEditor>copyright@wrbm.com (William Reed Business Media)</managingEditor>
    <webMaster>copyright@wrbm.com (William Reed Business Media)</webMaster>
    <pubDate>Fri, 24 May 2013 10:20:19 +0200</pubDate>
    <generator>eZ Components Feed dev (http://ezcomponents.org/docs/tutorials/Feed)</generator>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <ttl>60</ttl>
    <image>
      <url>http://www.nutraingredients.com/var/plain_site/storage/images/rss-feeds/nutraingredients-podcast/1263492-4-eng-GB/NutraIngredients-Podcast.gif|</url>
      <title>NutraIngredients Podcast</title>
      <link>http://www.nutraingredients.com</link>
    </image>
    <itunes:author>William Reed Business Media</itunes:author>
    <itunes:category text="Business">
      <itunes:category text="Business News"/>
    </itunes:category>
    <itunes:explicit>Clean</itunes:explicit>
    <itunes:image href="http://www.nutraingredients.com/var/plain_site/storage/images/rss-feeds/nutraingredients-podcast/1263492-4-eng-GB/NutraIngredients-Podcast.gif|"/>
    <itunes:owner>
      <itunes:email>copyright@wrbm.com</itunes:email>
      <itunes:name>William Reed Business Media</itunes:name>
    </itunes:owner>
    <itunes:subtitle>NutraIngredients Podcast</itunes:subtitle>
    <itunes:summary>Breaking News on Supplements &amp; Nutrition - Europe</itunes:summary>
    <item>
      <title>In vitro data still has an important place in EFSA dossiers, says expert</title>
      <link>http://www.nutraingredients.com/Research/In-vitro-data-still-has-an-important-place-in-EFSA-dossiers-says-expert?utm_source=RSS_videocast&amp;utm_medium=RSS%2Bfeed&amp;utm_campaign=RSS%2BVideocast</link>
      <description>Industry must not drop interest in mechanism focused, lab-based, in vitro studies in favour of chasing human trial data, according to&amp;#160;Dr Charles Czank of Leatherhead Food Research who argues that both in vitro and in vivo data are vital for a health claim.</description>
      <author>Nathan.GRAY@wrbm.com (Nathan GRAY)</author>
      <enclosure url="http://richmedia.decisionnewsmedia.com/content/download/377990/8147738/file/czank.mp4" length="24095816" type="video/mp4"/>
      <guid>http://www.nutraingredients.com/Research/In-vitro-data-still-has-an-important-place-in-EFSA-dossiers-says-expert?utm_source=RSS_videocast&amp;utm_medium=RSS%2Bfeed&amp;utm_campaign=RSS%2BVideocast</guid>
      <pubDate>Thu, 23 May 2013 14:25:31 +0200</pubDate>
      <itunes:author>Nathan GRAY</itunes:author>
      <itunes:keywords></itunes:keywords>
      <itunes:subtitle>In vitro data still has an important place in EFSA dossiers, says expert</itunes:subtitle>
      <itunes:summary>Industry must not drop interest in mechanism focused, lab-based, in vitro studies in favour of chasing human trial data, according to&amp;#160;Dr Charles Czank of Leatherhead Food Research who argues that both in vitro and in vivo data are vital for a health claim.</itunes:summary>
    </item>
    <item>
      <title>EFSA sets standard for study rigor, consultant says</title>
      <link>http://www.nutraingredients.com/Regulation/EFSA-sets-standard-for-study-rigor-consultant-says?utm_source=RSS_videocast&amp;utm_medium=RSS%2Bfeed&amp;utm_campaign=RSS%2BVideocast</link>
      <description>Differing regulatory environments can play havoc with a company's research plans, say consultant Joerg Gruenwald, PhD. &amp;#160;But recent, sometimes bitter, experience with the European Food Safety Authority has shed some light on how to negotiate this tangle, he said.</description>
      <author>Hank.Schultz@wrbm.com (Hank Schultz)</author>
      <enclosure url="http://richmedia.decisionnewsmedia.com/content/download/377115/8133782/file/gruenwald.mp4" length="29310527" type="video/mp4"/>
      <guid>http://www.nutraingredients.com/Regulation/EFSA-sets-standard-for-study-rigor-consultant-says?utm_source=RSS_videocast&amp;utm_medium=RSS%2Bfeed&amp;utm_campaign=RSS%2BVideocast</guid>
      <pubDate>Wed, 22 May 2013 14:58:03 +0200</pubDate>
      <itunes:author>Hank Schultz</itunes:author>
      <itunes:keywords>Health claims</itunes:keywords>
      <itunes:subtitle>EFSA sets standard for study rigor, consultant says</itunes:subtitle>
      <itunes:summary>Differing regulatory environments can play havoc with a company's research plans, say consultant Joerg Gruenwald, PhD. &amp;#160;But recent, sometimes bitter, experience with the European Food Safety Authority has shed some light on how to negotiate this tangle, he said.</itunes:summary>
    </item>
  </channel>
</rss>
